查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600181

药品契约製造市场：按服务、最终用户划分 - 2025-2030 年全球预测

Pharmaceutical Contract Manufacturing Market by Service, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品契约製造市场的市场规模为1,140.7亿美元，预计2024年将达到1,236.4亿美元，复合年增长率为8.46%，预计2030年将达到2014.6亿美元。

药品契约製造市场委託製药公司将製造服务（包括药品製造和包装）外包给专业的第三方组织。由于製药业对扩充性生产能力、成本效率和增加专业知识的需求不断增长，这一领域至关重要。契约製造主要应用于生技药品、原料药（API）、固态和固态剂型以及注射剂，并满足多个最终用户的生产需求，包括生物製药公司、学名药製造商和小型生物技术公司。市场成长的推动因素包括学名药需求的成长、生技药品製造复杂性的增加、监管要求的严格化以及製药业对成本控制的重视。新兴市场和持续的研发投资提供了潜在的成长机会，其中建立牢固的伙伴关係并专注于品质合规性至关重要。策略伙伴关係和合併以增强能力以获得市场占有率的趋势也在不断增长。然而，挑战包括激烈的竞争、监管合规的复杂性以及智慧财产权盗窃和资料外洩的风险。他们也受到建立先进製造设施和保持技术适应性的高成本的限制。连续製造、个人化医疗製造和先进包装解决方案等领域的创新至关重要。这些创新不仅确保了更高的效率，还能更好地回应客户的特定要求。此外，整合人工智慧和机器学习可以简化生产流程并改善供应链管理。对于业务成长而言，必须专注于建立强大的全球供应链网路并推动数位转型以保持竞争力。市场的协作性质非常重视品质保证和客户透明度，以确保成功。这些努力对于有效满足全球药品製造的动态需求和日益增加的复杂性至关重要。

主要市场统计
基准年[2023] 1140.7亿美元
预测年份 [2024] 1236.4亿美元
预测年份 [2030] 2014.6亿美元
复合年增长率（%） 8.46%

市场动态：揭示快速发展的药品契约製造市场的关键市场洞察

药品契约製造市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对学名药和生物疗法的需求不断增长
    • 加大医药研发与製造投入
    • CMO数量增加，先进製造技术投入加大
  • 市场限制因素
    • 序列化标准简介
  • 市场机会
    • 对特种药物的日益关注和核医学的有吸引力的领域
    • 对标靶治疗的细胞和基因治疗的需求不断增长
  • 市场挑战
    • 国家间贸易政策的变化

波特五力：驾驭药品契约製造市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药品契约製造市场的外部影响

外部宏观环境因素在塑造药品契约製造市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药品契约製造市场的竞争状况

药品契约製造市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 医药契约製造市场中的定位矩阵供应商绩效评估

FPNV定位矩阵是评估药品契约製造市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘药品契约製造市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，药品契约製造市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对学名药和生物疗法的需求增加
      • 加大医药研发与製造投入
      • CMO数量增加，先进製造技术投入加大
    • 抑制因素
      • 序列化标准简介
    • 机会
      • 对专科药物和核医学这一有吸引力的领域的关注日益增加
      • 对标靶治疗的细胞和基因治疗的需求不断增加
    • 任务
      • 国家间贸易政策的变化
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品契约製造市场：依服务分类

  • 生物製药製造服务
    • 生技药品原料药生产服务
    • 生物製品FDF製造服务
  • 药物开发服务
  • 药品製造服务
    • 医药原料药製造
      • 胶囊製造服务
      • 口服液製造服务
      • 注射剂/注射製造服务
      • 平板电脑製造服务
    • 製药FDF製造
  • 二次包装服务

第七章 药品契约製造市场：依最终用户分类

  • 大型製药公司
  • 学名药公司
  • 中小型製药公司

第 8 章：美洲药品契约製造市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太药品契约製造市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲药品契约製造市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Maiva Pharma 获得 1.19 亿美元投资，扩大霍苏尔新厂的生产规模
    • Kuehne Holding AG 从 BC Partners 手中收购 Aenova Group
    • Tonix Pharmaceuticals 与 Almac 合作开始 Tonmiya 的双源商业生产
    • Advent International 合併 Cohans Lifesciences 和 Sven Pharma
    • Aurobindo Pharma 与 Merck Sharp Corporation& Dohme 合作进入生技药品契约製造市场
  • 战略分析和建议

公司名单

  • AbbVie, Inc.
  • Aenova Group GmbH
  • Almac Group
  • Amgen Inc.
  • Baxter International Inc.
  • Biozoc Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • Curia Global, Inc.
  • Danaher Corporation
  • Dr. Reddy's Laboratories Ltd.
  • Elkos Group
  • Evonik Industries AG
  • Famar Group
  • Fareva Group
  • Jubilant Pharma Limited
  • Kryptochem Medicament Pvt. Ltd.
  • Lonza Group
  • Midas Pharma GmbH
  • Mitsubishi Tanabe Pharma Corporation
  • Nipro Group
  • Novartis AG
  • Pfizer Inc.
  • Pidolma Healthcare
  • PYRAMID Laboratories, Inc.
  • Recipharm AB
  • Serum Institute of India Ltd.
  • Siegfried Holding AG
  • Sycon Healthcare
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma-Fertigung GmbH & Co. KG
Product Code: MRR-030EE48515DD

The Pharmaceutical Contract Manufacturing Market was valued at USD 114.07 billion in 2023, expected to reach USD 123.64 billion in 2024, and is projected to grow at a CAGR of 8.46%, to USD 201.46 billion by 2030.

The pharmaceutical contract manufacturing market involves outsourcing manufacturing services, including drug production and packaging, by pharmaceutical companies to specialized third-party organizations. This sector is vital due to the pharmaceutical industry's growing need for scalable production capabilities, cost efficiency, and expertise enhancement. Contract manufacturing primarily finds application in biologics, active pharmaceutical ingredients (APIs), solid and semi-solid dosage forms, and injectables, addressing the production needs across multiple end-users such as biopharmaceutical companies, generic drug manufacturers, and small-scale biotech firms. Market growth is driven by the rising demand for generic drugs, the increasing complexity of manufacturing biologics, stringent regulatory requirements, and the emphasis on cost containment within the pharmaceutical industry. Emerging markets and continuous R&D investment provide potential growth opportunities, where developing strong partnerships and focusing on quality compliance can be decisive. There's a growing trend towards strategic partnerships and mergers, enhancing capabilities to capture market share. However, challenges include intense competition, regulatory compliance complexities, and the risk of intellectual property theft or data breaches. Other limitations involve the high cost of setting up advanced manufacturing facilities and maintaining technological adaptability. Innovation in areas like continuous manufacturing, personalized medicine production, and advanced packaging solutions is critical. These innovations not only ensure higher efficiency but also better address client-specific requirements. Furthermore, integrating artificial intelligence and machine learning can streamline production processes and improve supply chain management. For business growth, it's essential to focus on building robust global supply chain networks and advancing digital transformation to remain competitive. The market's nature is collaborative, with a growing emphasis on quality assurance and client transparency to succeed. Such efforts are crucial in responding effectively to the dynamic demands and growing complexities of pharmaceutical production globally.

KEY MARKET STATISTICS
Base Year [2023] USD 114.07 billion
Estimated Year [2024] USD 123.64 billion
Forecast Year [2030] USD 201.46 billion
CAGR (%) 8.46%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Contract Manufacturing Market

The Pharmaceutical Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Demand for Generics and Biological Therapies
    • Increasing Investments in Pharmaceutical R&D and Manufacturing
    • Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
  • Market Restraints
    • Introduction of Serialization Standards
  • Market Opportunities
    • Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector
    • Growing Demand for Cell and Gene Therapies for Targeted Treatment
  • Market Challenges
    • Changing Trade Policies Between Countries

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Contract Manufacturing Market

A detailed market share analysis in the Pharmaceutical Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Contract Manufacturing Market

A strategic analysis of the Pharmaceutical Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group GmbH, Almac Group, Amgen Inc., Baxter International Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc., Curia Global, Inc., Danaher Corporation, Dr. Reddy's Laboratories Ltd., Elkos Group, Evonik Industries AG, Famar Group, Fareva Group, Jubilant Pharma Limited, Kryptochem Medicament Pvt. Ltd., Lonza Group, Midas Pharma GmbH, Mitsubishi Tanabe Pharma Corporation, Nipro Group, Novartis AG, Pfizer Inc., Pidolma Healthcare, PYRAMID Laboratories, Inc., Recipharm AB, Serum Institute of India Ltd., Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma-Fertigung GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Biologics Manufacturing Services, Drug Development Services, Pharmaceutical Manufacturing Services, and Secondary Packaging Services. The Biologics Manufacturing Services is further studied across Biologics API Manufacturing Services and Biologics FDF Manufacturing Services. The Pharmaceutical Manufacturing Services is further studied across Pharmaceutical API Manufacturing and Pharmaceutical FDF Manufacturing. The Pharmaceutical API Manufacturing is further studied across Capsule Manufacturing Services, Oral Liquid Manufacturing Services, Parenteral/Injectable Manufacturing Services, and Tablet Manufacturing Services.
  • Based on End-User, market is studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Demand for Generics and Biological Therapies
      • 5.1.1.2. Increasing Investments in Pharmaceutical R&D and Manufacturing
      • 5.1.1.3. Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
    • 5.1.2. Restraints
      • 5.1.2.1. Introduction of Serialization Standards
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector
      • 5.1.3.2. Growing Demand for Cell and Gene Therapies for Targeted Treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Changing Trade Policies Between Countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Contract Manufacturing Market, by Service

  • 6.1. Introduction
  • 6.2. Biologics Manufacturing Services
    • 6.2.1. Biologics API Manufacturing Services
    • 6.2.2. Biologics FDF Manufacturing Services
  • 6.3. Drug Development Services
  • 6.4. Pharmaceutical Manufacturing Services
    • 6.4.1. Pharmaceutical API Manufacturing
      • 6.4.1.1. Capsule Manufacturing Services
      • 6.4.1.2. Oral Liquid Manufacturing Services
      • 6.4.1.3. Parenteral/Injectable Manufacturing Services
      • 6.4.1.4. Tablet Manufacturing Services
    • 6.4.2. Pharmaceutical FDF Manufacturing
  • 6.5. Secondary Packaging Services

7. Pharmaceutical Contract Manufacturing Market, by End-User

  • 7.1. Introduction
  • 7.2. Big Pharma
  • 7.3. Generic Pharmaceutical Companies
  • 7.4. Small & Mid-Size Pharma

8. Americas Pharmaceutical Contract Manufacturing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Maiva Pharma secures USD 119 million investment to expand manufacturing with new Hosur facility
    • 11.3.2. Kuhne Holding AG acquires Aenova Group from BC Partners
    • 11.3.3. Tonix Pharmaceuticals partners with Almac for dual-source commercial production of Tonmya
    • 11.3.4. Advent International merges Cohance Lifescience with Suven Pharma
    • 11.3.5. Aurobindo Pharma partners with Merck Sharp and Dohme to enter biologics contract manufacturing market
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Aenova Group GmbH
  • 3. Almac Group
  • 4. Amgen Inc.
  • 5. Baxter International Inc.
  • 6. Biozoc Inc.
  • 7. Boehringer Ingelheim International GmbH
  • 8. Cambrex Corporation
  • 9. Catalent, Inc.
  • 10. Curia Global, Inc.
  • 11. Danaher Corporation
  • 12. Dr. Reddy's Laboratories Ltd.
  • 13. Elkos Group
  • 14. Evonik Industries AG
  • 15. Famar Group
  • 16. Fareva Group
  • 17. Jubilant Pharma Limited
  • 18. Kryptochem Medicament Pvt. Ltd.
  • 19. Lonza Group
  • 20. Midas Pharma GmbH
  • 21. Mitsubishi Tanabe Pharma Corporation
  • 22. Nipro Group
  • 23. Novartis AG
  • 24. Pfizer Inc.
  • 25. Pidolma Healthcare
  • 26. PYRAMID Laboratories, Inc.
  • 27. Recipharm AB
  • 28. Serum Institute of India Ltd.
  • 29. Siegfried Holding AG
  • 30. Sycon Healthcare
  • 31. Thermo Fisher Scientific Inc.
  • 32. Vetter Pharma-Fertigung GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023